French Team Develops a Nasal COVID-19 Vaccine That Can Stop the Infection at the Nose

The idea of a nasal COVID-19 vaccine was already in the pipeline, but this time, French scientists have actually filed a patent application for a candidate vaccine. The vaccine will be administered through the nose and can block the infection in its first stages.

Nasal Spray

Nasal Spray

Read Also: A Vaccine against Most Coronaviruses May be Possible Study Shows

According to the French National Institute for Agricultural, Food, and Environmental Research (INRAE), pre-clinical tests on mice and golden hamsters with this vaccine, which is based on viral proteins encapsulated in nanoparticles made of starch and lipids, have yielded “very positive” results. Still, the results of this research have not yet been published in a peer reviewed scientific journal.

Read Also: A University of Arizona Study Shows That COVID-19 Kills Like a Venom That Spreads through the Body

According to INRAE and the University of Tours, the added value of this vaccine is that it can stop the spread of infection between humans by directly acting on the nasal mucosa. “Unlike intramuscular vaccines, only nasal vaccines can prevent the virus from entering the nose, which is the initial stage of infection. They stimulate immunity in the nasal mucosa, where the virus enters and multiplies,” the researchers explained in a press release.

Promising results in animals

Studies have shown that the vaccine stops the spread of infection very early. “I work with infected animals: after two days, I see that the virus spreads to the lungs. If I do the same with vaccinated and infected animals, I do not find any traces of the virus in the lungs,” explains Isabelle Dimier-Poisson, head of the BioMAP research team.

Read Also: A Promising French COVID-19 Vaccine Candidate Could Be Used to Boost Immunity in Previously Vaccinated People

Could be used as a Booster for previously vaccinated people

This non-adjuvanted vaccine, developed by French scientists and industrialists, could also be used as a booster vaccine in people who have already been vaccinated to prevent the transmission of the disease. According to the scientist, BioMAP has managed to achieve a 100% survival rate in mice vaccinated and subsequently infected with Covid-19, compared with a 100% mortality rate in unvaccinated mice.

The work of the BioMap team at INRAE and the University of Tours is based on a nanoparticle vaccine that was initially developed against toxoplasmosis and had shown a “100% efficacy in primates”.

The research team expects to start the manufacturing phase this autumn and the clinical phase in the second half of 2022. “Technically, the vaccine will be administered using a small adapter placed at the end of a needleless syringe to allow it to be injected into the nasal cavity,” says INRAE.

Final Thoughts

A COVID-19 vaccine delivered through the nose and that can stop the infection at the entry point would be a game-changer. Let’s hope that the French team succeeds so that we can all move on with our lives and forget this nightmare that has turned the world upside down for the past two years.

Read Also: Natural COVID-19 Infection Protects Better against the Delta Variant than the Pfizer Vaccine Israeli Study Shows

References

https://www.inrae.fr/actualites/vaccin-100-francais-administrable-voie-nasale-contre-covid-19-resultats-pre-cliniques-positifs

References

Targeting SARS-CoV-2 receptor-binding domain to cells expressing CD40 improves protection from infection in convalescent macaques

Articles you may like:

Police Recruitment Poor Standards: Physically Unfit Cops Are More Likely to Use Lethal Force

The Reasons Why Israel a Highly Vaccinated Country Has One of the Highest Infection Rates in the World

Is the Convenience of Using Toilet Paper Worth the Negative Impact They May Have On Your Health?

Chronic Pain Can Lead To Anxiety and Depression According to NeuRA Study

Chaga Mushrooms Health benefits: What does the science say?

Brain Health: Sleep Deprivation Negatively Affects Memory Study Shows

Giving Employees the Possibility to Take a 30 Minute Nap Improves Productivity

Global Food Security: Climate Change Is Likely to Cause More Plant Diseases Which Will Affect Crop Yield

Self Improvement: When Positive Thinking Becomes Unconducive to Success and Happiness

Vaccination rates below 90% Could Paradoxically Promote the Emergence of Resistant Variants

Nightmare Scenario: Could the Current Poorly Implemented Vaccination Campaign Lead to More Deadly SARS-CoV-2 Strains

Drinking Too Much Coffee Can Reduce Brain Size, and Cause Dementia

Possible Causes of the Sudden Fall In COVID-19 Infections in the UK and Europe

SARS-CoV-2 Transmissibility: Can You Really Catch COVID-19 through Flatulence (Farts)?

Moderna and Pfizer’s mRNA Vaccines Do Not Make Straight Men Gay

Researchers to Start Testing Male Contraceptive Gel

Gilmore Health News

Coronavirus: The Real and False Side Effects of COVID-19 Vaccines

Guillain-Barré Syndrome Observed after the First Dose of the AstraZeneca Vaccine

Sponsored:

Genf20 Plus

Growth Factor Plus Reviews

 

FEEDBACK:

Conversation

Want to Stay Informed?

Join the Gilmore Health News Newsletter!

Want to live your best life?

Get the Gilmore Health Weekly newsletter for health tips, wellness updates and more.

By clicking "Subscribe," I agree to the Gilmore Health and . I also agree to receive emails from Gilmore Health and I understand that I may opt out of Gilmore Health subscriptions at any time.